Paid in July so it will hit this period.
Would make so much sense for GSK just to buy the whole company.
Major pharmas do not want to own and operate bio-research companies. Supporting a variety of smaller firms on a specialty basis is better business for big pharma. They will buy when the science is closer to final approvals.